Alpha Centric Advisors LLC Reata Pharmaceuticals Inc Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Mar 09, 2022
SELL
$78.27 - $151.29 $195,675 - $378,225
-2,500 Closed
0 $0
Q1 2021

Mar 09, 2022
BUY
$94.25 - $132.81 $235,625 - $332,025
2,500 New
2,500 $249,000
Q4 2020

Mar 11, 2022
SELL
$102.03 - $184.62 $22,956 - $41,539
-225 Closed
0 $0
Q3 2020

Mar 11, 2022
BUY
$93.53 - $163.34 $21,044 - $36,751
225 New
225 $22,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email